Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,2-didecanoylglycerol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

17863-69-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 17863-69-3 Structure
  • Basic information

    1. Product Name: 1,2-didecanoylglycerol
    2. Synonyms: Bisdecanoic acid 3-hydroxy-1,2-propanediyl ester;Didecanoic acid 3-hydroxy-1,2-propanediyl ester;Glycerin 1,2-dicaprate;Decanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester;1-O,2-O-Didecanoyl-sn-glycerol;Bisdecanoic acid 1-(hydroxymethyl)ethylene ester
    3. CAS NO:17863-69-3
    4. Molecular Formula: C23H44O5
    5. Molecular Weight: 400.59
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 17863-69-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 481.9°Cat760mmHg
    3. Flash Point: 148°C
    4. Appearance: /
    5. Density: 0.969g/cm3
    6. Vapor Pressure: 2.77E-15mmHg at 25°C
    7. Refractive Index: 1.484
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 1,2-didecanoylglycerol(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1,2-didecanoylglycerol(17863-69-3)
    12. EPA Substance Registry System: 1,2-didecanoylglycerol(17863-69-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 17863-69-3(Hazardous Substances Data)

17863-69-3 Usage

Chemical class

Diacylglycerol

Structure

A glycerol molecule with two decanoyl (C10) fatty acid chains attached

Role

Precursor to the synthesis of triacylglycerols and phospholipids

Applications

Research and pharmaceutical

Involvement

Lipid metabolism and signaling pathways

Therapeutic potential

Cancer, inflammation, and metabolic disorders

Investigation

Role in cell signaling and as a potential target for drug development

Importance

Crucial role in lipid metabolism and potential implications in various biomedical applications

Check Digit Verification of cas no

The CAS Registry Mumber 17863-69-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,8,6 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17863-69:
(7*1)+(6*7)+(5*8)+(4*6)+(3*3)+(2*6)+(1*9)=143
143 % 10 = 3
So 17863-69-3 is a valid CAS Registry Number.
InChI:InChI=1/C23H44O5/c1-3-5-7-9-11-13-15-17-20(25)22(27)23(28,19-24)21(26)18-16-14-12-10-8-6-4-2/h22,24,27-28H,3-19H2,1-2H3

17863-69-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2-didecanoylglycerol

1.2 Other means of identification

Product number -
Other names 1,2-Didecanoylglycerol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17863-69-3 SDS

17863-69-3Relevant articles and documents

Short Communication. A potential chiral derivatizing agent for 1,2-diglycerides

Sonnet, Philip E.,Oliver, James E.,Waters, Roland M.,King, Gregory,Panicker, Sini

, p. 203 - 208 (1995)

Several chiral naphthylacetic acids have been prepared and evaluated as chiral derivatizing reagents for chiral alcohols.Fluorinated acids provide good general HPLC separations of chiral alcohols, especially 1,2-diglycerides.The separations and the 19F-NMR shift differences of pairs of diastereomers are documented. - Keywords: Chiral alcohols; 1,2-diglycerides; Fluoro-(1-naphthyl)acetic acids; Chiral derivatizing agents

Method for microwave synthesis of glyceryl caprylate-caprate

-

Paragraph 0029-0032; 0034-0037; 0039-0041; 0043-0046; 0048, (2017/07/20)

The invention provides a preparation method for microwave synthesis of glyceryl caprylate-caprate. Caprylate-caprate and glycerin are reacted in the presence of a compound catalyst, and a glyceryl caprylate-caprate product is prepared by microwave synthesis. According to the method, the molar ratio of caprylate and caprate in the glyceryl caprylate-caprate is regulated, catalysis of the compound catalyst is combined, and a frequency band of 300 to 3,000MHz is adopted for microwave synthesis, so that the high-quality glyceryl caprylate-caprate of which the molar ratio of the caprylate and the caprate is controllable can be efficiently and rapidly prepared. According to the method, a high esterification rate can be achieved, and meanwhile, the energy consumption and the production cost of a reaction process can be remarkably reduced.

Voriconazole derivative, synthesis thereof, and use thereof in long-acting preparation

-

Paragraph 0091, (2017/03/17)

The invention relates to a compound of formula (I), and a salt, an N-oxide, a quaternary ammonium and a stereoisomer thereof. R to R in the formula (I) are as defined in claims. The invention also relates to an intermediate for preparing the compound of formula (I), and a method for preparing the compound of formula (I). The invention further relates to a use of the compound of formula (I) as a drug especially used for preventing or treating fungal infection.

Fosaprepitant derivative, synthesis thereof, and use thereof in long acting preparation

-

Paragraph 0084, (2017/04/03)

The invention relates to a Fosaprepitant derivative, a synthesis thereof, and a use thereof in a long acting preparation. The invention relates to a compound of formula (I), and a salt, an N-oxide, a quaternary ammonium and a stereoisomer thereof. R to R in the formula (I) are as defined in claims. The invention also relates to an intermediate for preparing the compound of formula (I), and a method for preparing the compound of formula (I). The invention further relates to a use of the compound of formula (I) as a drug especially used for preventing chemotherapy induced acute and late nausea and vomiting.

Posaconazole derivative, synthesis and application in prolonged action preparation thereof

-

Paragraph 0089, (2017/04/03)

The invention relates to a posaconazole derivative, synthesis and an application in a prolonged action thereof. The invention relates to a formula of a compound and salt, N-oxide, quaternary ammonium and stereoisomer of the compound, wherein R1-R8 are defined according to what is claimed. The invention also relates to a preparation formula of an intermediate body and a method of the compound. The invention further relates to a formula of an application of the compound as a drug, especially the application in preventing or treating fungal infection. The detailed formulas are in the specification.

1-O-Alkyl (di)glycerol ethers synthesis from methyl esters and triglycerides by two pathways: Catalytic reductive alkylation and transesterification/reduction

Sutter, Marc,Dayoub, Wissam,Metay, Estelle,Raoul, Yann,Lemaire, Marc

supporting information, p. 786 - 797 (2013/04/24)

From available and bio-sourced methyl esters, monoglycerides or oleic sunflower refined oil, the corresponding 1-O-alkyl (di)glycerol ethers were obtained in both high yields and selectivity by two different pathways. With methyl esters, a reductive alkylation with (di)glycerol was realized under 50 bar hydrogen pressure in the presence of 1 mol% of Pd/C and an acid co-catalyst. A second two step procedure was evaluated from methyl esters or triolein and consisted of a first transesterification to the corresponding monoglyceride with a BaO/Al2O3 catalyst, then its reduction to the desired glycerol monoether with a recyclable heterogeneous catalytic system Pd/C and Amberlyst 35 under H2 pressure. In addition, a mechanism for the reaction was also proposed.

New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers

Coufalová, Lenka,Mrózek, Lech,Rárová, Lucie,Pla?ek, Luká?,Opat?ilová, Radka,Dohnal, Ji?í,Král'Ová, Katarína,Paleta, Old?ich,Král, Vladimír,Dra?ar, Pavel,Jampílek, Josef

, p. 435 - 453 (2013/06/27)

A series of final twelve propanoyloxy derivatives of 5β-cholan-24-oic acid (O-propanoyl derivatives of cholic acid) as potential drug absorption modifiers (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by 1H NMR, 13C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (log S), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukemia cell line and breast adenocarcinoma cell line. One compound showed selective cytotoxicity against human skin fibroblast cells and another compound possessed the highest cytotoxicity against all the tested cell lines. Only one compound expressed anti-proliferative effect on leukemia cancer cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50 > 37 μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and enhancement effect are discussed in this article.

FOSFLUCONAZOLE DERIVATIVES, SYNTHESIS, AND USE IN LONG ACTING FORMULATIONS

-

Page/Page column 28-30, (2010/10/03)

The invention relates to a compound of formula (I) and the salts, N-oxides, quaternary amines, and stereoisomers thereof, wherein R1 to R8 are as defined in the claims. The invention further relates to intermediates and methods for the preparation of the compounds of formula (I). The invention also relates to the compounds of formula (I) for use as a medicament, particularly for the prevention or treatment of fungal infections.

Enzymatic synthesis of symmetrical 1,3-diacylglycerols by direct esterification of glycerol in solvent-free system

Rosu, Roxana,Yasui, Mamoru,Iwasaki, Yugo,Yamane, Tsuneo

, p. 839 - 843 (2007/10/03)

1,3-Diacylglycerols were synthesized by direct esterification of glycerol with free fatty acids in a solvent-free system. Free fatty acids with relatively low melting points (45°C) such as unsaturated and medium-chain saturated fatty acids were used. With stoichiometric ratios of the reactants and water removal by evaporation at 3 mm Hg vacuum applied at 1 h and thereafter, the maximal 1,3-diacylglycerol content in the reaction mixture was: 84.6% for 1,3-dicaprylin, 84.4% for 1,3-dicaprin, 74.3% for 1,3-dilinolein, 71.7% for 1,3-dieicosapentaenoin, 67.4% for 1,3-dilaurin, and 61.1% for 1,3-diolein. Some of the system's parameters (temperature, water removal, and molar ratio of the reactants) were optimized for the production of 1,3-dicaprylin, and the maximal yield reached 98%. The product was used for the chemical synthesis of 1,3-dicapryloyl-2-eicosapentaenoylglycerol. The yield after purification was 42%, and the purity of the triacylglycerol was 98% (both 1,3-dicapryloyl-2-eicosapentaenoylglycerol and 1,2-dicapryloyl-3-eicosapentaenoylglycerol included) by gas chromatographic analysis, of which 90% was the desired structured triacylglycerol (1,3-dicapryloyl-2-eicosapentaenoylglycerol) as determined by silver ion high-performance liquid chromatographic analysis.

New synthesis of sn-1,2- and sn-2,3-O-diacylglycerols application to the synthesis of enantiopure phosphonates analogous to triglycerides: A new class of inhibitors of lipases

Marguet, Frank,Cavalier, Jean-Francois,Verger, Robert,Buono, Gerard

, p. 1671 - 1678 (2007/10/03)

Phosphonate compounds mimic the first transition state occurring during enzymatic carboxyester hydrolysis of natural substrates by forming a covalent bond with the catalytic serine. However, until now the organophosphorus compounds used in the inhibition studies more or less resembled a natural triglyceride substrate. In order to elucidate the interfacial activation and the mechanism of action of lipases, specific inhibitors need to be prepared. To achieve this goal, enantiomerically pure sn-1,2- and sn-2,3O- didecanoylglycerol compounds were prepared - starting from a C-4 chiral synthon, 3-buten-1,2-diol - and treated with n-pentylphosphonic dichloride and p-nitrophenol to afford the corresponding diastereomeric phosphonates, which were acylglycerol analogs. Subsequent separation of each of the phosphonate diastereomers A/B or ent-A/ent-B, performed by HPLC, led to four enantiopure stereoisomers that will be investigated as inhibitors of Human Pancreatic Lipase (HPL) and Human Gastric Lipase (HGL) using the monomolecular film technique.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17863-69-3